EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

LOGO   Nanometrics Incorporated    Tel: 408.545.6000
  1550 Buckeye Drive    Fax: 408.232.5910
  Milpitas, CA 95035    www.nanometrics.com

 

Investor Relations Contact:       Company Contact:
Claire McAdams       James Moniz, CFO
Headgate Partners LLC       Nanometrics Incorporated
530.265.9899, 530.265.9699 fax       408.545.6145, 408.521.9370 fax
email: claire@headgatepartners.com       email: jmoniz@nanometrics.com

Nanometrics Reports Fourth Quarter and Full Year 2008 Financial Results

Cash Increases to $24 Million; Revenues Decline 12%; Quarterly Operating Expenses Decrease 15% to $12 Million

MILPITAS, Calif., February 19, 2009 — Nanometrics Incorporated (Nasdaq: NANO), a leading supplier of advanced process control metrology systems used primarily in the manufacturing of semiconductors, solar photovoltaics and high-brightness LEDs, today announced financial results for its fourth quarter and full year ended December 27, 2008.

Highlights for the fourth quarter include:

 

   

Cash increased by $2.2 million (10%) in the quarter, ending the year with $24.0 million

 

   

Revenue of $20.5 million, down 12% compared to the third quarter of 2008

 

   

Operating expenses of $12.1 million declined 15% sequentially; cash operating expenses of $10.1 million

 

   

Gross margin of 42% comprised of 40% product gross margin and 46% service gross margin

“In a difficult market environment, our fourth quarter results are indicative of the progress we have made to streamline our cost structure, cut expenses and improve our balance sheet management, while continuing to develop and introduce new products,” commented Dr. Timothy J. Stultz, president and chief executive officer. “With a backdrop of a 12% decline in revenues from the previous quarter, we increased cash by 10%, cut ongoing operating expenses by 15% and maintained gross margins above 40%. Today, our new products continue to gain traction, and over half of our revenues are derived from sources outside of traditional semiconductor capacity expansion activity.”

“Over the last several quarters we have made significant progress to reduce our cash breakeven level, and in fact we generated cash from operations in the fourth quarter,” added Dr. Stultz. “We will continue to seek opportunities to size our spending to the current business environment while maintaining our focus on balance sheet management and competitive products. With the near-term outlook for semiconductor capital spending continuing to weaken, our management efforts are directed at maintaining a sound financial and liquidity position while not compromising our ability to respond to a future recovery in semiconductor capital spending.”

Fourth Quarter 2008 Summary

Revenues were $20.5 million, down 12% from $23.1 million in the third quarter of 2008 and down 38% from $33.2 million in the fourth quarter of 2007. Included in total sales were a record $7.6 million in service revenues, which benefited by strong upgrade sales in the quarter. Gross margin was 42.1%, down from 44.1% for the prior quarter and 44.1% in the year-ago period. Operating expenses were $12.1 million, a 15% decrease from the prior quarter (exclusive of the restructuring and impairment charges taken in the third quarter of 2008) and down 24% from the year-ago period.


The net loss was $2.6 million, or $0.14 per share. This compares to a net loss of $60.4 million, or $3.25 per share, in the third quarter of 2008 (which included $56.0 million in asset impairment and restructuring charges, equivalent to $3.01 per share) and a net loss of $1.3 million, or $0.07 per share, in the fourth quarter of 2007. The net loss for the fourth quarter of 2008 included $0.7 million for stock-based compensation expense, compared to $1.1 million in the prior quarter and $1.0 million in the year-ago period.

Earnings (loss) before interest, income taxes, depreciation and amortization excluding certain items such as asset impairment, restructuring and acquisition-related charges (“EBITDA”) for the fourth quarter was ($2.0) million, compared to ($2.2) million for the third quarter of 2008 and $1.2 million for the fourth quarter of 2007.

Selected Revenue Segment Information for the Fourth Quarter of 2008

 

Revenues by Product

        

Revenues by Region

      

Automated Metrology

   42 %  

United States

   40 %

Integrated Metrology

   5 %  

Japan

   16 %

Materials Characterization

   16 %  

South Korea

   33 %

Service

   37 %  

ROW

   11 %

Full Year 2008 Summary

Revenues were $102.1 million, down 30% from $146.3 million in 2007. Gross margin was 43.8%, an increase compared to 42.1% in the prior year. Total research and development, selling, general and administrative expenses were $54.6 million, down 9% from $59.8 million for 2007. Total operating expenses, which include amortization of intangible assets, impairment and restructuring charges, were $128.2 million, compared to $65.7 million in the prior year. The net loss was $82.7 million, or $4.46 per share, compared to a net loss of $4.0 million, or $0.22 per share, for 2007. The net loss for 2008 included $68.5 million in asset impairment charges, $1.5 million in restructuring charges and $3.9 million in stock-based compensation expense. Earnings (loss) before interest, income taxes, depreciation and amortization excluding certain items such as asset impairment, restructuring and acquisition-related charges (“EBITDA”) was ($5.0) million for 2008, compared to $6.9 million for 2007.

Conference Call Details

A conference call to discuss the fourth quarter and full year 2008 results will be held later today at 5:00 p.m. EST (2:00 p.m. PST). To participate in the conference call, the dial-in numbers are 800-510-9691 for domestic callers and 617-614-3453 for international callers. The passcode is 64880278. A live and recorded webcast will be made available on the investor page of the Nanometrics website at www.nanometrics.com.

Use of Non-GAAP Financial Information

Financial results such as EBITDA that exclude certain charges and special items are not in accordance with U.S. Generally Accepted Accounting Principles (GAAP). Management uses EBITDA, which excludes costs associated with acquisitions, asset impairments, restructuring and other special items, to evaluate the company’s operating and financial results. The company believes the presentation of EBITDA is useful to investors for analyzing ongoing business trends, comparing performance to prior periods, and enhancing the investor’s ability to view the company’s results from management’s perspective. A table presenting a reconciliation of GAAP results to EBITDA is included at the end of this press release.

About Nanometrics

Nanometrics is a leader in the design, manufacture and marketing of high-performance process control metrology systems used primarily in the manufacturing of semiconductors, solar photovoltaics and high-brightness LEDs, as well as by customers in the silicon wafer and data storage industries. Nanometrics standalone and integrated metrology systems measure various thin film properties, critical dimensions, overlay control and optical, electrical and material properties, including the structural composition of silicon, compound semiconductor and photovoltaic


devices, during various steps of the manufacturing process. These systems enable device manufacturers to improve yields, increase productivity and lower their manufacturing costs. The company maintains its headquarters in Milpitas, California, with sales and service offices worldwide. Nanometrics is traded on NASDAQ Global Market under the symbol NANO. Nanometrics’ website is http://www.nanometrics.com.

Forward Looking Statements

This press release contains forward-looking statements including, but not limited to, statements regarding Nanometrics’ expected results for its most recently completed fiscal quarter and year, which remain subject to adjustment in connection with the preparation of Nanometrics’ financial statements and periodic report on Form 10-K for the year ended December 27, 2008. For additional information and considerations regarding the risks faced by Nanometrics, see its annual report on Form 10-K, as amended, for the year ended December 30, 2007 as filed with the Securities and Exchange Commission, as well as other periodic reports filed with the SEC from time to time. Although Nanometrics believes that the expectations reflected in the forward-looking statements are reasonable, Nanometrics cannot guarantee future results, levels of activity, performance or achievements. Nanometrics disclaims any obligation to update information contained in any forward-looking statement.


NANOMETRICS INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited for 2008)

 

     December 27,
2008
    December 29,
2007
 
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 23,980     $ 14,919  

Accounts receivable, net of allowances of $309 and $323

     17,143       34,855  

Inventories

     31,583       33,343  

Inventories - delivered systems

     205       785  

Prepaid expenses and other

     1,838       2,598  

Deferred income tax assets

     350    
                

Total current assets

     75,099       86,500  

Property, plant and equipment, net

     40,136       44,419  

Goodwill and indefinite lived intangible assets

       52,532  

Intangible assets, net

     6,901       21,820  

Other assets

     1,718       1,805  
                

Total assets

   $ 123,854     $ 207,076  
                
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Revolving line of credit

   $ —       $ —    

Accounts payable

     4,824       13,931  

Accrued payroll and related expenses

     3,435       4,514  

Deferred revenue

     1,701       2,501  

Other current liabilities

     5,800       7,243  

Income taxes payable

     1,187       1,101  

Current portion of debt obligations

     413       148  
                

Total current liabilities

     17,360       29,438  

Deferred income taxes

     —         382  

Other long- term liabilities

     644       1,283  

Debt obligations due after one year

     13,083       129  
                

Total liabilities

     31,087       31,232  

Stockholders’ equity

    

Common stock, $0.001 par value; 47,000,000 shares authorized; 18,413,054 and 18,620,682, respectively, outstanding

     18       19  

Additional paid-in capital

     189,919       187,180  

Accumulated deficit

     (96,643 )     (13,917 )

Accumulated other comprehensive income

     (527 )     2,562  
                

Total stockholders’ equity

     92,767       175,844  
                

Total liabilities and stockholders’ equity

   $ 123,854     $ 207,076  
                


NANOMETRICS INCORPORATED

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited except for the year ended December 29, 2007)

 

     Three Months Ended     Year Ended  
     December 27,
2008
    December 29,
2007
    December 27,
2008
    December 29,
2007
 

Net revenues:

        

Products

   $ 12,852     $ 27,485     $ 75,596     $ 126,049  

Service

     7,623       5,708       26,505       20,241  
                                

Total net revenues

     20,475       33,193       102,101       146,290  
                                

Costs of net revenues:

        

Cost of products

     7,718       13,310       38,692       63,938  

Cost of service

     4,127       5,258       18,675       20,717  
                                

Total costs of net revenues

     11,845       18,568       57,367       84,655  
                                

Gross profit

     8,630       14,625       44,734       61,635  

Operating expenses:

        

Research and development

     4,003       4,591       17,110       18,577  

Selling

     3,835       4,925       17,798       19,561  

General and administrative

     3,928       5,166       19,689       21,704  

Amortization of intangible assets

     316       1,285       3,531       5,782  

Restructuring charge

     —         —         1,525       2,128  

Asset impairment

     —         —         68,545       —    

Gain on sale of assets

     —         —         —         (2,100 )
                                

Total operating expenses

     12,082       15,967       128,198       65,652  
                                

Income (loss) from operations

     (3,452 )     (1,342 )     (83,464 )     (4,017 )

Other income (expense):

        

Interest income

     29       81       185       202  

Interest expense

     (292 )     (70 )     (635 )     (211 )

Other, net

     1,060       27       1,624       (13 )
                                

Total other income (expense), net

     797       38       1,174       (22 )
                                

Income (loss) before income tax provision (benefit)

     (2,655 )     (1,304 )     (82,290 )     (4,039 )

Income tax provision (benefit)

     (14 )     (29 )     436       (31 )
                                

Net income (loss)

   $ (2,641 )   $ (1,275 )   $ (82,726 )   $ (4,008 )
                                

Net income (loss) per share:

        

Basic

   $ (0.14 )   $ (0.07 )   $ (4.46 )   $ (0.22 )
                                

Diluted

   $ (0.14 )   $ (0.07 )   $ (4.46 )   $ (0.22 )
                                

Shares used in per share computation:

        

Basic

     18,385       18,604       18,546       18,099  
                                

Diluted

     18,385       18,604       18,546       18,099  
                                


NANOMETRICS INCORPORATED

RECONCILIATION OF GAAP RESULTS TO EBITDA

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended     Year Ended  
     December 27,
2008
    December 29,
2007
    December 27,
2008
    December 29,
2007
 

Loss from operations

   $ (3,452 )   $ (1,342 )   $ (83,464 )   $ (4,017 )

Adjustments:

        

Amortization of intangible assets

     316       1,285       3,531       5,782  

Depreciation

     843       1,081       3,675       3,576  

Amortization of demonstration systems

     342       207       1,223       1,578  

Restructuring charge

     —         —         1,525       2,128  

Asset impairment

     —         —         68,545       —    

Gain on sale of assets

     —         —         —         (2,100 )
                                

Earnings (loss) before interest, income taxes, depreciation and amortization excluding certain items (“EBITDA”)

   $ (1,952 )   $ 1,231     $ (4,966 )   $ 6,947